Drug classes

Nitazenes linked to 179 deaths in 12 months, government data show

According to data analysis by the Office for Health Improvement and Disparities, protonitazene was linked to the most reported deaths — 73 out of 179.…

Cardiac chest pain: identification, referral and management in primary care

Chest discomfort is a common symptom with several possible causes. This article outlines how pharmacists can differentiate symptoms and identify when patients are likely to be experiencing myocardial ischaemia.…

Manufacturer withdraws treatment for sickle cell disease following concern over deaths

Pfizer's withdrawal is based on data that suggest “an imbalance in vast-occlusive crises and fatal events which require further assessment”.…

Prescribing dilemma: balancing risk and benefits of off-label migraine treatment in a child

The second of a new series of articles exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…

Lipid-lowering therapies for the secondary prevention of cardiovascular disease in primary care

An overview of updated guidance relating to the secondary prevention of cardiovascular disease can be applied in practice, considering the availability of newer medications.…

Everything you need to know about the NHS antibiotic subscription model

Following what has been deemed a successful pilot, NHS England is hoping that its new subscription model will boost drug development by paying manufacturers a fixed fee for antimicrobials.…

Test your knowledge of sexual and reproductive health

This CPD and learning quiz can help you assess your knowledge of a range of sexually transmitted infections and related health issues.…

Almost 40 million deaths could occur from AMR over next 25 years, study results suggest

The researchers based their estimations on analysis of global AMR data from 1990 to 2021.…

Pharmacists made 150,000 patient interventions during anticoagulant safety audits, report finds

The results of the two national audits revealed a significant increase in patients with a yellow anticoagulant alert card, from 66.5% in 2021/2023 to 73.3% in 2023/2024.…

Mpox: how is the UK preparing for the latest variant?

With the first cases of a new mpox strain emerging in Europe and Asia in August 2024, the World Health Organization has declared the outbreak as a “public health emergency of international concern” for the second time in two years. So what is the ‘clade I’ mpox virus and what risk does it po…